https://tissuepathology.com Educational and informative Tue, 26 May 2026 12:11:11 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/05/26/pictor-labs-launches-nvidia-powered-on-prem-ai-staining-at-uscap-2026-boasting-99-100-stain-equivalence/ Tue, 26 May 2026 12:11:11 +0000 https://tissuepathology.com/?p=24440 Pictor Labs, the UCLA spinout behind a suite of AI-powered virtual staining tools, used USCAP 2026, the annual pathology meeting in Los Angeles, to debut a dedicated on-premises hardware system that runs its full product line, including ClearStain, ReStain and DeepStain, entirely within a lab’s own walls. Pictor Labs has offered cloud-based virtual staining since it commercially launched […]

The post Pictor Labs launches NVIDIA-powered on-prem AI staining at USCAP 2026, boasting 99-100% stain equivalence first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/21/grundium-acquires-visiopharm-to-create-integrated-precision-pathology-platform/ Thu, 21 May 2026 12:59:00 +0000 https://tissuepathology.com/?p=24433 Grundium Acquires Visiopharm: The combined platform brings together digital slide scanning and AI-driven precision pathology software to accelerate accessible and scalable adoption of precision diagnostics TAMPERE, FI AND COPENHAGEN, DK / ACCESS Newswire / May 21, 2026 / Grundium Oy, a leader in advanced digital scanning backed by US-based healthcare private equity firm EW Healthcare Partners, has today […]

The post Grundium Acquires Visiopharm to Create Integrated Precision Pathology Platform first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/19/astrazeneca-collaborates-with-roche-diagnostics-asia-pacific-to-help-accelerate-sustainable-ecosystem-for-advanced-pathology-in-breast-and-lung-cancer/ Tue, 19 May 2026 12:26:00 +0000 https://tissuepathology.com/?p=24425 SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care across nine Asia markets, a first in the region. This landmark collaboration aims to accelerate the adoption of AI-powered digital and computational pathology through educational and training initiatives and improve […]

The post AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/18/regarding-techcyte-and-biobase-partnership-on-linkedin/ Mon, 18 May 2026 12:19:24 +0000 https://tissuepathology.com/?p=24422 From LinkedIn regarding Techcyte and Biobase partnership Sam Seymour, CPO and Co-Founder at Biobase: I started in digital pathology over 6 years ago at Paige (now Tempus AI). Not a lot has changed since then; digital pathology’s adoption problem has always been the ROI math. The companies that are seeing success in the market have […]

The post Regarding Techcyte and Biobase Partnership on LinkedIn first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/13/owkin-to-build-ai-agents-as-part-of-a-multi-year-k-pro-license-agreement-with-astrazeneca/ Wed, 13 May 2026 11:52:28 +0000 https://tissuepathology.com/?p=24414 Agreement includes a license for Owkin AI Scientist, K Pro, for three years. As part of this license, Owkin will develop novel biopharma agents for AstraZeneca, usable through K Pro. This will include capabilities to quickly analyze and forecast the competitive landscape for specific pharmaceutical targets, assets, and trials. NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, the […]

The post Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/11/%f0%9d%90%91%f0%9d%90%a8%f0%9d%90%9c%f0%9d%90%a1%f0%9d%90%9e-%f0%9d%90%80%f0%9d%90%9c%f0%9d%90%aa%f0%9d%90%ae%f0%9d%90%a2%f0%9d%90%ab%f0%9d%90%9e%f0%9d%90%ac-%f0%9d%90%8f%f0%9d%90%9a%f0%9d%90%ad/ Mon, 11 May 2026 13:46:48 +0000 https://tissuepathology.com/?p=24407 Regarding the Roche acquisition of PathAI, from Elizabeth Bourn on LinkedIn: This morning, Roche announced that it had entered into a definitive merger agreement to acquire PathAI for $750M upfront, with up to $300M in additional milestone payments. Both vendors hope with this acquisition will scale the adoption of Digital Pathology, not only in routine […]

The post Roche Aquires PathAI: Implications for the Digital Pathology Market first appeared on Tissuepathology.com.]]>